1. (a) “Adverse event” means an event in which an animal is injured, sickened, rendered unconscious, or killed.
2. (b) “Animal” includes, but is not limited to, any domesticated fowl or nonhuman mammal or any wild fowl, bird, or mammal that is reduced to captivity.
3. (c) “Best clinical practice” means making clinical decisions that are based on up-to-date scientific knowledge. This includes, but is not limited to, guidelines and publications by the American Veterinary Medical Association (AVMA), AVMA-recognized specialty organizations, the Association of Veterinary Hematology and Transfusion Medicine, AVMA-accredited veterinary colleges, the Association for the Advancement of Blood and Biotherapies, and government organizations.
4. (d) “Biologics” means all viruses, serums, antibody products, toxins (excluding substances that are selectively toxic to microorganisms, such as antibiotics), or analogous products at any stage of production, shipment, distribution, or sale, which are intended for use in the treatment of animals and that act primarily through the direct stimulation, supplementation, enhancement, or modulation of the immune system or immune response.
5. (e) “Blood and blood component products” means whole blood collected directly from a donor animal for transfusion or the blood components for transfusion, including packed red blood cells, platelet-rich plasma, platelet concentrates, fresh plasma, fresh frozen plasma, frozen plasma, cryoprecipitate, cryosupernatant, lyophilized plasma, and albumin. Antibody products, such as hyperimmune serums, are excluded from this definition.
6. (f) “Captive closed colony” means that an animal is kept, housed, or maintained in any way for the purpose of collecting its blood.
7. (g) “Closed-colony blood bank” means a commercial blood bank for animals that produces animal blood or blood component products solely from animals held in a captive closed colony.
8. (h) “Commercial blood bank for animals” means an establishment that produces animal blood or blood component products from captive closed-colony or community-sourced animals to market and sell for use in the cure, mitigation, treatment, or prevention of injury or disease in animals.
9. (i) “Community blood bank” means a commercial blood bank for animals that produces animal blood or blood component products solely from community-sourced animals whose owners voluntarily consent to the donation.

10. (j) “Community sourced animal” means that an animal is all of the following:

    1. (1) Kept, housed, and maintained at the residence of its owner who is a person and not a partnership, association, corporation, or limited liability company.
    2. (2) Brought by its owner to a community blood bank to have its blood collected.
    3. (3) Licensed in accordance with any pet licensing required by the pet owner's state, county, or city of residence.
11. (k) “Department” means the California Department of Food and Agriculture.
12. (l) “Production” means collection of blood or the preparation, testing, processing, storage, or distribution of blood or blood component products for the purpose of transfusion.
13. (m) “Quarterly reporting period” means a calendar year quarter. For reporting purposes these shall be January 1 through March 31; April 1 through June 30; July 1 through September 30; and October 1 through December 31.
14. (n) “Standards of care” means the level of care, skill, and treatment that, in the light of all relevant surrounding circumstances, is recognized as acceptable and appropriate by reasonably prudent licensed veterinarians. This includes, but is not limited to, guidelines published by the American Veterinary Medical Association, the American College of Veterinary Internal Medicine, the California Veterinary Medical Association, AVMA-accredited veterinary colleges, and government organizations.

Note: Authority cited: Sections 407 and 9251, Food and Agricultural Code. Reference: Section 9201, Food and Agricultural Code; and Section 4920, Business and Professions Code.

History

1. New chapter 8 (articles 1-5), article 1 (section 1303) and section filed 3-10-2025; operative 7-1-2025 (Register 2025, No. 11). For prior history of chapter 8 (articles 1-6, sections 1305.00-1305.12), see Register 2019, No. 3.